3Elewski BE.Onychomycosis:treatment quality of life and economic issues[J].Am J Clin Dermatol,2000,1(1):19-26.
4Haven CT.Dont bite the hand that feeds you[J].Ciln Llbora Science,1996,9(3):155.
5Williams JGK,Kubelik AR,Livak KJ,et al.DNA polymorphisms amplified by arbitrary primers are useful as genetic markers[J].Nucleic Acids Res,1990,18(22):6531-6535.
6Lin DM,Lehmann PF.Random amplified polymorphic DNA for strain delineation within Candida tropicalis[J].J Med Vet Mycol,1995,33(4):241-246.
7Lir D,Coloe S,Baird R,et al.Molecular determination of dermatophyte fungi using the arbitrarily primed polymerase chain reaction[J].Br J Dermatol,1997,137(3):351-355.
8Vazquez JA,Beckley A,Sobel JD,et al.Comparison of restriction enzyme analysis and pulsed-field gradient gel electrophoresis as typing systems for Candida analysis and pulsed-field gradient gel electrophoresis as typing systems for Candida albicans[J].J Clin Microbiol,1991,29(5):962-967.
9Bostock A,Khattak MN,Matthews R,et al.Comparison of PCR fingerpinting by random amplification of polymorphic DNA with other molecular typing methods for Candida albicans[J].J Gen Microbiol,1993,139(9):2179-2184.
10Rosen T.New approaches to the diagnosis and management of onychomycosis:international symposium,Monaco,April 1-2,1993[J].Int J Dermatol,1994,33(4):292-299.
